参考文献/References:
1 李力军,马林,吕大鹏,等.现代高新技术治疗恶性肿瘤.北京:人民军医出版社,2003.133-153.
2 尹伯元.临床核素治疗学.北京:人民军医出版社,2003.169-180.
3 王俊杰,唐劲天,黎功.放射性粒子近距离治疗肿瘤.北京:北京医科大学出版社,2001.112-124.
4 Pommer P, Delannes M, Lefloch O, et al. The French preliminary experience of the use of a seed-projector for exclusive iodine-125 prostate brachytheray:feasibility and acute toxicity. Cancer Radiother, 2006, 9(1):5.
5 潘中允.放射性核素治疗学.北京:人民卫生出版社,2006.451.
6 Ragde H, Grado GL, Nadir BS. Brachytheray for clinically localized prostate cancer thirteen-year disease-free survical of 769 consecutive prostate cancer patients treated with permanent implants alone. Arch Esp Urol, 2001, 54(3):739-747.
7 Sharkey, Cantor A, Sole Z, et al. Brachytheray versus radical prostatectomy in patient with clinically localized prostate cancer.Curr Urol Rep, 2002, 3(2):250-257.
8 Merrick GS, Butter WM, Dorsey AT, et al. Seed fixity in the prostate/Reriprostic region following brachytherapy. Int J Radiat Oncol Biol Phys, 2000, 46(1):215-240.
9 Zelefsky M J, Hollister T, Raben A, et al. Five-year biochemical outcome and toxicity with transperineal CT-panned permanent I-125 prostate implantation for patients with localized prostate cancer. Int J Radiat Oncol Biol Phys. 2001, 47(2):1261-1266.
10 Livsey J, Cowan RA, Wylie JP, et al. Hypofractionated conformal radio therapy incarcinoma of the prostate:five-year outcome analysis. Int J Radiat Oncol Biol Phys, 2003, 57(1):1254-1259.
11 Larson DA, Suplica JM, Chang SM, et al Permanent iodine-125 brachytherapy in patients with progressive or recurrent glioblastoma multiforme. Neuro-Oncol. 2004, 6(2):119-126.
12 Wilkowski R, Thoma M, Duhmke E, et al. Concurrent chemoradiotherapy with gemcitabine and cisplatin after incomplete (R1) resection of locally advanced pancreatic carcinoma. Int J Radiat Oncol Biol Phys, 2004, 58(3):768-772.
13 Peretz T, Nol D, Hilaris B, et al. Treatment ofprimary unresectable carcinoma of the pancreas with I implantation. Int J Radiation Oncology Biology Physics, 1989, 17(5):931-935.
14 Martinez-Monge R, Nag S, Nieroda CA, et al. Iodione-125 brachytherapy in the treatment of colorectal adenocarcinoma metastasis to the liver. Cancer, 1999, 85(6):1218-1225.
15 徐静,梅铭惠,陈谦,等.术中组织间植入125I粒子治疗肝恶性肿瘤.中华实验外科杂志,2004,16(1):29-31.
16 邵文博,宋金龙.125I粒子近距离照射对BEL-7402肝癌细胞增殖和细胞周期的影响.中国医学物理学杂志,2005,22(4):567.
相似文献/References:
[1]梁雯丽,郑艳,李娜,等.Graves甲亢患者131I治疗后早期TRAb及TSAb变化的研究分析[J].国际放射医学核医学杂志,2016,40(1):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
Liang Wenli,Zheng Yan,Li Na,et al.Analysis of the changes in early TRAb and TSAb after 131I treatment for patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):13.[doi:10.3760/cma.j.issn.1673-4114.2016.01.003]
[2]邓艳,张伟.125I-碘酞酸盐临床应用进展[J].国际放射医学核医学杂志,2016,40(3):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
Deng Yan,Zhang Wei.125I-iothalamate clinical applications[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):225.[doi:10.3760/cma.j.issn.1673-4114.2016.03.012]
[3]田琦,张丽花,蒋宁一.甲状腺癌131I治疗后合并骨髓增生异常综合征一例[J].国际放射医学核医学杂志,2016,40(3):235.[doi:10.3760/cma.j.issn.1673-4114.2016.03.014]
[4]田琦,蒋宁一,郑丽.265例精细个体化131I治疗Graves甲亢的疗效观察[J].国际放射医学核医学杂志,2016,40(4):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
Tian Qi,Jiang Ningyi,Zheng Li.Therapeutic effect of fine individual 131I treatment on Graves disease hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):259.[doi:10.3760/cma.j.issn.1673-4114.2016.04.004]
[5]杨珂,唐波,于夕荣,等.甲状腺癌131i治疗病房的辐射屏蔽计算与评价[J].国际放射医学核医学杂志,2015,39(5):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
yang ke,tang bo,yu xirong,et al.shielding calculation and assessment in 131i therapy for thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):405.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 012]
[6]霍小东,王慧星,阎卫亮,等.血管内皮抑制素对125I近距离照射裸鼠肺癌移植瘤的增敏效应研究[J].国际放射医学核医学杂志,2016,40(5):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
Huo Xiaodong,Wang Huixing,Yan Weiliang,et al.Sensitization effect of endostatin for 125I brachytherapy on transplanted tumor in nude mice[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):357.[doi:10.3760/cma.j.issn.1673-4114.2016.05.006]
[7]刘娇,程兵,常伟,等.非高危分化型甲状腺癌低剂量和高剂量131I清甲疗效的分析[J].国际放射医学核医学杂志,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
Liu Jiao,Cheng Bing,Chang Wei,et al.Ablation efficacy in non-high-risk differentiated thyroid carcinoma patients with low-dose and high-dose 131I[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):419.[doi:10.3760/cma.j.issn.1673-4114.2016.06.004]
[8]王越,晋建华,李思进,等.甲状腺24h摄碘率与131I治疗Graves甲亢疗效相关性研究[J].国际放射医学核医学杂志,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
Wang Yue,Jin Jianhua,Li Sijin,et al.Correlation between thyroid 24 h of radioactive iodine uptake and clinical efficacy of 131I therapy for Graves’ hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):442.[doi:10.3760/cma.j.issn.1673-4114.2015.06.002]
[9]张丽花,蒋宁一.131I治疗Graves甲亢合并肝功能损害或血细胞减少的优势与风险[J].国际放射医学核医学杂志,2015,39(6):483.[doi:10.3760/cma.j.issn.1673-4114.2015.06.010]
Zhang Lihua,Jiang Ningyi.The advantage and risk of 131I treatment in hyperthyroidism combined with liver injury or blood cell reduction[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):483.[doi:10.3760/cma.j.issn.1673-4114.2015.06.010]
[10]杨宝军.131I治疗甲亢合并特发性血小板减少性紫癜一例[J].国际放射医学核医学杂志,2015,39(6):511.[doi:10.3760/cma.j.issn.1673-4114.2015.06.017]
[11]徐蓉生,梅艳,赵力威,等.B超引导下术中125I粒子植入治疗晚期胰腺癌的疗效评价[J].国际放射医学核医学杂志,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
Xu Rongsheng,Mei Yan,Zhao Liwei,et al.Evaluation of 125I particle implantation in the treatment of patients with advanced pancreatic neoplasms using B ultrasound-guided surgery[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(6):424.[doi:10.3760/cma.j.issn.1673-4114.2016.06.005]
[12]赵腾,梁军,林岩松.131I治疗前刺激性Tg在分化型甲状腺癌风险评估及治疗决策中的意义[J].国际放射医学核医学杂志,2015,39(1):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
Zhao Teng,Liang Jun,Lin Yansong.The role of preablative stimulated thyroglobulin in guiding risk estimation and therapeutic decisions of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(6):61.[doi:10.3760/cma.j.issn.1673-4114.2015.01.013]
[13]俞秀华,黄炜坤,林玉梅.131I治疗Graves病合并肝损害的临床观察[J].国际放射医学核医学杂志,2014,38(2):90.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]
Yu Xiuhua,Huang Weikun,Lin Yumei.Clinical observation of 131I therapy in Graves disease patients with hepatic dysfunction[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):90.[doi:10.3760/cma.j.issn.1673-4114.2014.02.005]
[14]张俊涛.晚期肺癌125I粒子植入治疗近期疗效观察[J].国际放射医学核医学杂志,2014,38(2):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
Zhang Juntao.Short-term efficacy of 125I seeds implantation in the treatment of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):94.[doi:10.3760/cma.j.issn.1673-4114.2014.02.006]
[15]成钊汀,谭建.分化型甲状腺癌术后患者131I治疗的辐射剂量与防护[J].国际放射医学核医学杂志,2014,38(2):110.[doi:10.3760/cma.j.issn.1673-4114.2014.02.010]
Cheng Zhaoting,Tan Jian.Radiation dose and protection of differentiated thyroid carcinoma postoperative patients with 131I treatment[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):110.[doi:10.3760/cma.j.issn.1673-4114.2014.02.010]
[16]李永军,徐兆强,柳卫,等.分化型甲状腺癌术后131I治疗患者胸腺生理性摄取131I的临床研究[J].国际放射医学核医学杂志,2014,38(4):227.[doi:10.3760/cma.j.issn.1673-4114.2014.04.005]
Li Yongjun,Xu Zhaoqiang,Liu Wei,et al.Clinical research on physiological thymic uptake of 131I in post-operative patients with differentiated thyroid cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):227.[doi:10.3760/cma.j.issn.1673-4114.2014.04.005]
[17]张璐,詹维伟,张一帆.颈部超声在分化型甲状腺癌131I治疗中的应用进展[J].国际放射医学核医学杂志,2014,38(4):271.[doi:10.3760/cma.j.issn.1673-4114.2014.04.015]
Zhang Lu,Zhan Weiwei,Zhang Yifan.Application of neck ultrasonography in 131I radiotherapy of differentiated thyroid carcinoma[J].International Journal of Radiation Medicine and Nuclear Medicine,2014,38(6):271.[doi:10.3760/cma.j.issn.1673-4114.2014.04.015]
[18]郑艳,赵德善,付松海,等.儿童和青少年Graves甲亢患者131Ⅰ治疗剂量的分析研究[J].国际放射医学核医学杂志,2013,37(2):69.[doi:10.3760/cma.j.issn.1673-4114.2013.02.002]
ZHENG Yan,ZHAO De-shan,FU Song-hai,et al.The dose analysis of 131Ⅰ treatment in pediatric patients with Graves hyperthyroidism[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):69.[doi:10.3760/cma.j.issn.1673-4114.2013.02.002]
[19]甄作武,林坚,杨锦钊,等.影像引导下125Ⅰ粒子组织间植入近距离治疗肿瘤的应用进展[J].国际放射医学核医学杂志,2013,37(2):116.[doi:10.3760/cma.j.issn.1673-4114.2013.02.014]
ZHEN Zuo-wu,LIN Jian,YANG Jin-zhao,et al.Application and progress of image-guided 125Ⅰ seed interstitial implantation for the treatment of tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):116.[doi:10.3760/cma.j.issn.1673-4114.2013.02.014]
[20]廖江荣,蒲德利,程毅力,等.经纤支镜和经皮联合植入125I粒子治疗晚期肺癌气管狭窄的临床分析[J].国际放射医学核医学杂志,2013,37(3):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]
LIAO Jiang-rong,PU De-li,CHENG Yi-li,et al.The clinical analysis of 125I particles implantation by fibrobronchoscope and percutaneous in the treatment of tracheal stenosis of advanced lung cancer[J].International Journal of Radiation Medicine and Nuclear Medicine,2013,37(6):165.[doi:10.3760/cma.j.issn.1673-4114.2013.03.009]